Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Malnutrition in COPD
NCT04861649Unknown
- Sponsor
- Asclepius Meditec
- Start
- Mar 2021
- Primary completion
- Jun 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Open-label, single-arm trial of allogeneic fecal microbiota in Malnutrition, sponsored by Asclepius Meditec. Primary endpoints: Changes of intestinal flora in COPD malnutrition subjects at 6 months, Nutritional indicators in COPD malnutrition subjects at 6 months and 1 more. Status: unknown.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Malnutrition
Beyond the preview
Go deeper on NCT04861649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04861649.